TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 174 filers reported holding TRAVERE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $160,750 | -48.5% | 17,981 | -11.5% | 0.10% | -47.0% |
Q2 2023 | $311,946 | -16.8% | 20,309 | +21.8% | 0.18% | -10.2% |
Q1 2023 | $374,998 | +8.9% | 16,674 | +1.8% | 0.21% | +14.4% |
Q4 2022 | $344,492 | +39.5% | 16,381 | +63.5% | 0.18% | +83.7% |
Q3 2022 | $247,000 | +3.3% | 10,019 | +1.5% | 0.10% | +10.1% |
Q2 2022 | $239,000 | -34.3% | 9,875 | -30.0% | 0.09% | -45.4% |
Q1 2022 | $364,000 | -16.9% | 14,116 | 0.0% | 0.16% | -1.2% |
Q4 2021 | $438,000 | -38.8% | 14,116 | -52.2% | 0.16% | -47.6% |
Q3 2021 | $716,000 | +52.0% | 29,543 | -8.4% | 0.32% | +62.4% |
Q2 2021 | $471,000 | -21.1% | 32,254 | +34.9% | 0.19% | -23.0% |
Q1 2021 | $597,000 | – | 23,907 | – | 0.25% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,084,300 | $15,820,000 | 3.32% |
ARMISTICE CAPITAL, LLC | 5,748,000 | $83,863,000 | 1.50% |
RA Capital Management | 5,614,428 | $81,915,000 | 1.32% |
Krensavage Asset Management, LLC | 140,000 | $2,043,000 | 0.69% |
CM Management, LLC | 60,000 | $875,000 | 0.63% |
Altium Capital Management LP | 170,484 | $2,487,000 | 0.58% |
HighVista Strategies LLC | 53,498 | $781,000 | 0.55% |
Sio Capital Management, LLC | 150,000 | $2,189,000 | 0.54% |
MANGROVE PARTNERS IM, LLC | 295,037 | $4,305,000 | 0.44% |
Rock Springs Capital Management LP | 1,494,164 | $21,800,000 | 0.43% |